[CONTRIBUTION TO THE EXPERIMENTAL STUDY OF A NEW ANTI-INFLAMMATORY AGENT, "A-230"].
D015065:17-Hydroxycorticosteroids; D000038:Abscess; D000311:Adrenal Glands; D000315:Adrenalectomy; D000700:Analgesics; D018712:Analgesics, Non-Narcotic; D000893:Anti-Inflammatory Agents; D058633:Antipyretics; D001205:Ascorbic Acid; D002784:Cholesterol / Q000097:blood*; D003911:Dextrans; D004487:Edema; D005557:Formaldehyde; D006099:Granuloma; D006632:Histamine; D007249:Inflammation; D007274:Injections, Intraperitoneal; D010653:Phenylbutazone; D010827:Physiology; D051381:Rats; D012701:Serotonin; D013442:Sulfinpyrazone
D015065:17-Hydroxycorticosteroids; D000700:Analgesics; D018712:Analgesics, Non-Narcotic; D000893:Anti-Inflammatory Agents; D058633:Antipyretics; D003911:Dextrans; D005557:Formaldehyde; D012701:Serotonin; D006632:Histamine; D002784:Cholesterol; D010653:Phenylbutazone; D001205:Ascorbic Acid; D013442:Sulfinpyrazone
17-HYDROXYCORTICOSTEROIDS; ABSCESS; ADRENAL GLANDS; ADRENALECTOMY; ANALGESICS AND ANTIPYRETICS; ANTI-INFLAMMATORY AGENTS; ASCORBIC ACID; BLOOD CHOLESTEROL; DEXTRAN; EDEMA; FORMALDEHYDE; GRANULOMA; HISTAMINE; INFLAMMATION; INJECTIONS, INTRAPERITONEAL; PHENYLBUTAZONE; PHYSIOLOGY; RATS; SEROTONIN; SULFINPYRAZONE
CONTRIBUTION 'A L''ETUDE EXP'ERIMENTALE D'UN NOUVEL ANTI-INFLAMMATOIRE, LE "230 A".